dengue shock syndrome
Information
- Disease name
- dengue shock syndrome
- Disease ID
- DOID:0050125
- Description
- "A dengue disease that involves the most severe form of dengue fever, has_material_basis_in Dengue virus [NCBITaxon:12637] with four serotypes (Dengue virus 1, 2, 3 and 4), which are transmitted_by Aedes mosquito bite. The infection has_symptom easy bruising, has_symptom blood spots, has_symptom bleeding gums, and has_symptom nosebleeds. It is accompanied by circulatory collapse, involves hypotension, narrow pulse pressure (less than or equal to 20mm Hg), or frank shock. The shock occurs after two to six days of symptoms, followed by collapse, weak pulse, and blueness around the mouth." [url:http\://en.wikipedia.org/wiki/Dengue_shock_syndrome]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00468858 | Completed | Phase 2 | A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children | July 2007 | April 2010 |
| NCT00919178 | Completed | Phase 1 | Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus | July 2009 | May 2010 |
| NCT04048837 | Completed | Prospective Study for the Evaluation of Dengue Prognostic Biomarkers in Singapore | July 30, 2018 | July 1, 2019 | |
| NCT04673422 | Completed | Phase 2/Phase 3 | Effect of Montelukast in Preventing Dengue With Warning Signs in Dengue Patients | January 15, 2021 | June 17, 2023 |
| NCT04837430 | Recruiting | NT-proBNP and Troponin I in Dengue Children | April 2, 2021 | December 31, 2023 | |
| NCT00966628 | Unknown status | Phase 3 | Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) | May 2008 | December 2009 |
- Disase is a (Disease Ontology)
- DOID:12205
- Exact Synonym (Disease Ontology)
- DSS
- MedGen concept unique identifier (MedGen Concept name)
- C0376300
- MedGen unique identifier (MedGen Concept name)
- 83958